login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
GRAIL INC (GRAL) Stock News
USA
- NASDAQ:GRAL -
US3847471014
-
Common Stock
78
USD
-8.41 (-9.73%)
Last: 10/17/2025, 8:17:15 PM
82.3
USD
+4.3 (+5.51%)
After Hours:
10/17/2025, 8:17:15 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
GRAL Latest News, Press Relases and Analysis
All
Press Releases
3 hours ago - By: GRAIL, Inc.
GRAIL PATHFINDER 2 Results Show Galleri ® Multi-Cancer Early Detection Blood Test Increased Cancer Detection More Than Seven-Fold When Added to USPSTF A and B Recommended Screenings
a day ago - By: The Motley Fool
Why Grail Stock Soared 14% Higher on Thursday
2 months ago - By: GRAIL, Inc.
GRAIL Reports Second Quarter 2025 Financial Results
a day ago - By: Benzinga
- Mentions:
DDD
SLI
JBHT
CRM
...
Enerpac Tool Group Posts Upbeat Results, Joins Praxis Precision Medicines, J B Hunt, Salesforce And Other Big Stocks Moving Higher On Thursday
2 days ago - By: GRAIL, Inc.
Samsung and GRAIL Announce Strategic Collaboration to Bring GRAIL's Galleri® Multi-Cancer Early Detection Test to Asia
21 days ago - By: The Motley Fool
This Cancer Detection Pioneer Is Worth a Look
25 days ago - By: GRAIL, Inc.
GRAIL to Present New Galleri® Data From More Than 32,000 Participants Across the PATHFINDER 2, SYMPLIFY and REFLECTION Studies at ESMO Congress 2025 and EDCC
a month ago - By: GRAIL, Inc.
GRAIL to Present at Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum
3 months ago - By: GRAIL, Inc.
GRAIL to Announce Second Quarter 2025 Financial Results
5 months ago - By: Zacks Investment Research
Stock Market News for May 23, 2025
2 months ago - By: GRAIL, Inc.
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2 months ago - By: GRAIL, Inc.
GRAIL to Present at Morgan Stanley 23rd Annual Global Healthcare Conference
2 months ago - By: Zacks Investment Research
- Mentions:
BHST
BioHarvest Sciences Inc. (BHST) Reports Q2 Loss, Misses Revenue Estimates
2 months ago - By: Zacks Investment Research
- Mentions:
FEMY
Femasys Inc. (FEMY) Reports Q2 Loss, Lags Revenue Estimates
2 months ago - By: Zacks Investment Research
- Mentions:
LFCR
Lifecore Biomedical (LFCR) Reports Q4 Loss, Tops Revenue Estimates
2 months ago - By: Benzinga
- Mentions:
BKV
IMCC
VALN
PRTS
...
Earnings Scheduled For August 12, 2025
3 months ago - By: GRAIL, Inc.
GRAIL to Present at Canaccord Genuity 45th Annual Growth Conference
3 months ago - By: Yahoo Finance
- Mentions:
MS
ILMN
GS
Grail (GRAL) PT Hiked to $38 at Morgan Stanley amid ‘Equal Weight’ Stance
4 months ago - By: GRAIL, Inc.
GRAIL Announces Positive Top-Line Results From The Galleri® PATHFINDER 2 Registrational Study
5 months ago - By: GRAIL, Inc.
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
5 months ago - By: GRAIL, Inc.
GRAIL to Present at Jefferies Global Healthcare Conference 2025
5 months ago - By: Yahoo Finance
- Mentions:
DAVA
TSEM
ARCO
Endava Sees No Relief Up Ahead
Please enable JavaScript to continue using this application.